Webinars
-
mRNA LNP Scale Up For GMP Vaccine Production
4/14/2022
Explore an overview of the development and scale-up activities needed to develop high quality lipid nanoparticles and progress this saRNA vaccine to the clinic.
-
Democratizing RNA Nanotherapeutics
4/14/2022
This webinar is presented by Dr. John P. Cooke, Chair of the Department of Cardiovascular Sciences at the Houston Methodist Research Institute, Director of the Center for Cardiovascular Regeneration, and Medical Director of the RNA Therapeutics Program in the Houston Methodist DeBakey Heart and Vascular Center.
-
RNA Therapeutics: Going Beyond The Liver
4/14/2022
This TeaTime Webinar is presented by Dr. Dan Peer, Professor and Director, Laboratory of Precision NanoMedicine at Tel Aviv University.
-
Nanomedicine Today And Tomorrow: How The European Tech Platform Is Driving Nanomedicine Forward
4/14/2022
This Tea Time Webinar is presented by Dr. Ruth Schmid, Vice President Marketing at SINTEF in Trondheim, Norway, with a special responsibility for the field of medical technology, including nanomedicine at SINTEF.
-
Overcoming Key Challenges In Vaccine Development
4/14/2022
View an overview presentation of vaccine development and learn how to overcome some key challenges with Precision NanoSystems Inc.'s field application scientist, Dr. Ian Villamagna.
-
Polysarcosine-Functionalized Lipid Nanoparticles For Therapeutic mRNA Delivery
4/14/2022
This Tea Time Webinar is presented by Dr. Heinrich Haas, Vice President RNA Formulation & Drug Delivery at BioNTech.
-
RNA Vaccine Development To Phase I
4/14/2022
Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.
-
DNA Vaccine Development In A Global Pandemic: A Personal Account
4/14/2022
Dr. Gerrit Borchard, University of Geneva, presents a personal account of DNA vaccine development in a global pandemic.
-
Scale Up And Manufacturing Of RNA-LNPs For A COVID-19 Vaccine
4/13/2022
Dr. Jason Coleman, Clinical Application Scientist Lead with Precision NanoSystems, presents on an overview of the development and scale-up activities needed to progress this saRNA vaccine to the clinic.
-
Molecular And Colloidal Ionization Properties Of Lipid Nanoparticle mRNA Vaccines
4/13/2022
Dr. Michael Buschmann, George Mason University, presents an overview of molecular and colloidal ionization properties of lipid nanoparticle mRNA vaccines.